ES2044860T3 - Estables aductos con disolventes de z-1-(p-beta-di-metil-amino-etoxi-fenil)-1-(p-hidroxi-fenil)-2-fenil-but-1-eno. - Google Patents
Estables aductos con disolventes de z-1-(p-beta-di-metil-amino-etoxi-fenil)-1-(p-hidroxi-fenil)-2-fenil-but-1-eno.Info
- Publication number
- ES2044860T3 ES2044860T3 ES87105803T ES87105803T ES2044860T3 ES 2044860 T3 ES2044860 T3 ES 2044860T3 ES 87105803 T ES87105803 T ES 87105803T ES 87105803 T ES87105803 T ES 87105803T ES 2044860 T3 ES2044860 T3 ES 2044860T3
- Authority
- ES
- Spain
- Prior art keywords
- fenil
- eno
- beta
- solvents
- etoxi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
- C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
LA INVENCION SE REFIERE A NUEVOS ADUCTOS ESTEREOQUIMICAMENTE PUROS Y ESTABLES DE Z-1-(P-BETA-DIMETILAMINO 1(P-HIDROXIFENIL)-2-FENILBUT-1-ENO Y DETERMINADOS DISOLVENTES QUE, DEBIDO A SU NOTABLE ACTIVIDAD HORMONAL, PUEDEN SER APLICADOS EN EL TRATAMIENTO TERAPEUTICO DE ENFERMEDADES BENIGNAS DEL PECHO Y TUMORES DE MAMA DEPENDIENTES DE LAS HORMONAS, EN ESPECIAL MEDIANTE APLICACION PERCUTANE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP87105803A EP0287690B1 (de) | 1987-04-21 | 1987-04-21 | Stabile Lösungsmitteladdukte von Z-1-(p-beta-Dimethylamino-ethoxyphenyl)-1-(p-hydroxyphenyl)-2-phenylbut-1-en |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2044860T3 true ES2044860T3 (es) | 1994-01-16 |
Family
ID=8196934
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES87105803T Expired - Lifetime ES2044860T3 (es) | 1987-04-21 | 1987-04-21 | Estables aductos con disolventes de z-1-(p-beta-di-metil-amino-etoxi-fenil)-1-(p-hidroxi-fenil)-2-fenil-but-1-eno. |
Country Status (18)
Country | Link |
---|---|
US (1) | US4973755A (es) |
EP (1) | EP0287690B1 (es) |
JP (1) | JP2596446B2 (es) |
KR (1) | KR940010274B1 (es) |
AR (1) | AR243494A1 (es) |
AT (1) | ATE80152T1 (es) |
AU (1) | AU607198B2 (es) |
CA (1) | CA1305972C (es) |
DE (1) | DE3781546D1 (es) |
DK (1) | DK171748B1 (es) |
ES (1) | ES2044860T3 (es) |
GR (1) | GR3005582T3 (es) |
HU (1) | HU204501B (es) |
IE (1) | IE62488B1 (es) |
IL (1) | IL85804A (es) |
NZ (1) | NZ224296A (es) |
PT (1) | PT87268B (es) |
ZA (1) | ZA882016B (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5811447A (en) | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6251920B1 (en) | 1993-05-13 | 2001-06-26 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies |
US5770609A (en) * | 1993-01-28 | 1998-06-23 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies |
US6491938B2 (en) | 1993-05-13 | 2002-12-10 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
CA2162586C (en) * | 1993-05-13 | 2006-01-03 | David J. Grainger | Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells |
US6197789B1 (en) | 1995-06-07 | 2001-03-06 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
KR0169186B1 (ko) * | 1993-10-25 | 1999-03-20 | 고바야시 유끼오 | 트리페닐에틸렌 화합물의 z이성체 산부가염의 제조방법 |
DE4407742C1 (de) * | 1994-03-08 | 1995-06-22 | Hexal Pharma Gmbh | Transdermales System in Form eines Pflasters mit einem Tamoxifen-Derivat |
US5650425A (en) * | 1994-04-04 | 1997-07-22 | Pharmos Corporation | Permanently ionic derivatives of steroid hormones and their antagonists |
AU725286B2 (en) | 1996-01-20 | 2000-10-12 | Bradford University | Tamoxifen and analogues thereof |
GB9601167D0 (en) * | 1996-01-20 | 1996-03-20 | Univ Bradford | Tamoxifen and analogues thereof |
US6083990A (en) * | 1997-04-02 | 2000-07-04 | Pharmos Corporation | Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones |
WO1998046588A2 (en) * | 1997-04-11 | 1998-10-22 | Neorx Corporation | Compounds and therapies for the prevention of vascular and non-vascular pathologies |
GB9715479D0 (en) * | 1997-07-23 | 1997-10-01 | Univ Bradford | Tamoxifen and analogues thereof |
EP1043986B1 (en) * | 1997-12-23 | 2003-04-16 | Hexal Ag | Mixture and pharmaceutical composition comprising z-4-hydroxytamoxifen and cyclodextrin |
EP1572171B1 (en) * | 2002-12-18 | 2009-04-22 | Laboratoires Besins International | Reduction of breast density with 4-hydroxy tamoxifen |
DE60305068T2 (de) * | 2002-12-18 | 2007-01-11 | Laboratoires Besins International | Behandlung von mastalgie mit 4-hydroxy-tamoxifen |
NZ542499A (en) * | 2003-04-01 | 2008-10-31 | Besins Int Lab | Prevention and treatment of breast cancer with 4-hydroxy tamoxifen |
ES2304610T3 (es) * | 2003-06-09 | 2008-10-16 | Ascend Therapeutics, Inc. | Tratamiento y prevencion de cicatrizacion excesiva con 4-hidroxi-tamoxifeno. |
EP1643946A2 (en) * | 2003-06-20 | 2006-04-12 | Viral Genomix, Inc. | Compositions for and methods for treating hiv |
US7968532B2 (en) * | 2003-12-15 | 2011-06-28 | Besins Healthcare Luxembourg | Treatment of gynecomastia with 4-hydroxy tamoxifen |
US7507769B2 (en) * | 2004-03-22 | 2009-03-24 | Laboratoires Besins International | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
DK1748770T3 (da) * | 2004-03-22 | 2008-08-04 | Besins Int Lab | Behandling og forebyggelse af benign brystsygdom med 4-hydroxy-tamoxifen |
EP1579856A1 (en) * | 2004-03-22 | 2005-09-28 | Laboratoires Besins International | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE637389A (es) * | 1962-09-13 | |||
GB1099093A (en) * | 1965-09-03 | 1968-01-17 | Ici Ltd | Alkene derivatives |
GB1560274A (en) * | 1977-02-28 | 1980-02-06 | Ici Ltd | Phenylbut 1-ene derivatives having antiostrogenicactivity |
EP0002097B1 (en) * | 1977-08-22 | 1981-08-05 | Imperial Chemical Industries Plc | Triphenylalkene derivatives, process for their preparation and pharmaceutical compositions containing them |
DE3046719C2 (de) * | 1980-12-11 | 1983-02-17 | Klinge Pharma GmbH, 8000 München | 1,1,2-Triphenyl-but-1-en-Derivate, Verfahren zu ihrer Herstellung und Arzneimittel |
DE3239610A1 (de) * | 1982-10-26 | 1984-04-26 | Klinge Pharma GmbH, 8000 München | Neue 1,1,2-triphenyl-but-l-en-derivate, sowie verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
-
1987
- 1987-04-21 AT AT87105803T patent/ATE80152T1/de not_active IP Right Cessation
- 1987-04-21 EP EP87105803A patent/EP0287690B1/de not_active Expired - Lifetime
- 1987-04-21 DE DE8787105803T patent/DE3781546D1/de not_active Expired - Fee Related
- 1987-04-21 ES ES87105803T patent/ES2044860T3/es not_active Expired - Lifetime
-
1988
- 1988-03-21 IL IL85804A patent/IL85804A/xx not_active IP Right Cessation
- 1988-03-22 ZA ZA882016A patent/ZA882016B/xx unknown
- 1988-03-25 CA CA000562434A patent/CA1305972C/en not_active Expired - Lifetime
- 1988-03-28 AU AU13798/88A patent/AU607198B2/en not_active Ceased
- 1988-04-07 DK DK189888A patent/DK171748B1/da not_active IP Right Cessation
- 1988-04-12 AR AR88310542A patent/AR243494A1/es active
- 1988-04-15 JP JP63093309A patent/JP2596446B2/ja not_active Expired - Fee Related
- 1988-04-18 HU HU881980A patent/HU204501B/hu not_active IP Right Cessation
- 1988-04-19 IE IE117288A patent/IE62488B1/en not_active IP Right Cessation
- 1988-04-19 US US07/183,068 patent/US4973755A/en not_active Expired - Lifetime
- 1988-04-19 NZ NZ224296A patent/NZ224296A/xx unknown
- 1988-04-19 KR KR1019880004433A patent/KR940010274B1/ko not_active IP Right Cessation
- 1988-04-19 PT PT87268A patent/PT87268B/pt not_active IP Right Cessation
-
1992
- 1992-09-03 GR GR920401142T patent/GR3005582T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE3781546D1 (de) | 1992-10-08 |
EP0287690B1 (de) | 1992-09-02 |
NZ224296A (en) | 1990-02-26 |
CA1305972C (en) | 1992-08-04 |
ZA882016B (en) | 1988-12-28 |
PT87268A (pt) | 1988-05-01 |
GR3005582T3 (es) | 1993-06-07 |
EP0287690A1 (de) | 1988-10-26 |
HU204501B (en) | 1992-01-28 |
DK189888D0 (da) | 1988-04-07 |
AU607198B2 (en) | 1991-02-28 |
AU1379888A (en) | 1988-10-20 |
HUT50318A (en) | 1990-01-29 |
JP2596446B2 (ja) | 1997-04-02 |
US4973755A (en) | 1990-11-27 |
IL85804A (en) | 1991-07-18 |
AR243494A1 (es) | 1993-08-31 |
IL85804A0 (en) | 1988-09-30 |
PT87268B (pt) | 1992-08-31 |
ATE80152T1 (de) | 1992-09-15 |
DK189888A (da) | 1988-10-22 |
IE62488B1 (en) | 1995-02-08 |
JPS6445347A (en) | 1989-02-17 |
KR880012528A (ko) | 1988-11-28 |
KR940010274B1 (ko) | 1994-10-22 |
DK171748B1 (da) | 1997-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2044860T3 (es) | Estables aductos con disolventes de z-1-(p-beta-di-metil-amino-etoxi-fenil)-1-(p-hidroxi-fenil)-2-fenil-but-1-eno. | |
DK420385D0 (da) | Antioestrogent laegemiddel til perkutan indgift | |
DK124091D0 (da) | Farmaceutisk genprodukt | |
SE8202172L (sv) | Topiska farmaceutiska kompositioner | |
HUP9904045A2 (hu) | Progeszteron alkalmazása iszkémia kezelésére vagy enyhítésére | |
ES421538A1 (es) | Procedimiento para la obtencion de derivados de alcanolami-na. | |
FR2434155A1 (fr) | Derives d'imidazole et leur utilisation pour le traitement des maladies provoquees par le thromboxane a2 | |
OA09478A (fr) | "Utilisation de la N-myristoyl-(S)-phénylalaine pour l'obtention de médicaments destinés au traitement des maladies faisant intervenir la myristoylation". | |
EP0151989A3 (en) | Means for the treatment of cardiac diseases | |
SE7600563L (sv) | Forfarande for framstellning av antracyklinoner | |
IS1565B (is) | Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar | |
SE8802569D0 (sv) | Improvements in or relation to somatostatins | |
IT1224594B (it) | Impiego in terapeutica di derivati del 4h-benzo-4,5-cicloepta-1,2-bqti ofene | |
DE69113982D1 (de) | Neue 15,16-seco-19-nor-progestine. | |
ES2037278T3 (es) | Tratamiento de la esterilidad. | |
ES2115582T3 (es) | Preparacion y aplicaciones de interferon-gamma. | |
KR910009270A (ko) | 15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법 | |
GB1431169A (en) | Operation tables and chairs | |
AR008155A1 (es) | Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres. | |
SE8201308D0 (sv) | Alkylendiaminderivat och forfarande for framstellning derav | |
ES2059615T3 (es) | Empleo del derivado de tiazol tiprotimoda para la preparacion de un agente para la terapia de infecciones por virus. | |
FR2187321A1 (en) | Flavoured extract of water lilies - with antihaemorrhagic activity | |
HK49680A (en) | Pharmaceutical preparations for the treatment of coronary heart diseases | |
DE3579074D1 (de) | Verminderung der toxischen wirkungen von anthrachinon-medikamenten. | |
USD194230S (en) | Table mat or similar article |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 287690 Country of ref document: ES |